AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer

This study is currently recruiting participants.

Study NCT00770848 Information provided by Amgen

First Received: October 9, 2008 Last Updated: November 5, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	March 2013
Estimated Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)